In the GO analysis (Table 2), three common targets between active compounds and RA appeared in two terms: “protein heterodimerization activity” (VEGFA, FOS, and TP53) and “RNA polymerase II transcription factor binding” (STAT3, FOS, and TP53), both belonging to the “molecular function” category. This evidence concerns the gene FOS and rheumatoid arthritis.